The Atticus Group Strategic Consulting Firm Celebrates 5th Anniversary

Share Article

Firm has partnered with numerous companies in the U.S. and Europe to support the commercialization of new medical technologies

The Atticus Group, LLC, a privately held consulting company which provides strategic business development and tactical marketing solutions to medical technology companies, announced today the celebration of its 5-year anniversary. Since its inception, The Atticus Group has worked with numerous emerging medical technology companies to assist with strategic market development initiatives prior to product launch and to support pre- and post-launch product commercialization activities. The company’s clients include U.S. and European-based companies with innovative medical devices and personalized medicine-focused molecular diagnostic tests.

“It has been exciting for us to work hand in hand with our clients over the past 5 years as they have brought new medical technologies to the market,” stated Larry Yost, the Company’s Founder and Managing Partner. “Our expertise and broad experience across many areas of medicine and medical specialties have allowed us to provide strategic insight and creative marketing solutions to a broad range of companies. We also appreciate the many referrals and networking opportunities our customers have provided us which have supported our efforts to build The Atticus Group. We are extremely enthusiastic about the future and will continue to take steps to expand our business and to work with our clients to develop and implement effective business and marketing strategies which help them to achieve and exceed their expectations.”


Founded in 2009, The Atticus Group’s mission is to partner with medical technology companies to assist with business development and strategic marketing initiatives and to support the implementation of innovative tactical marketing solutions which drive revenue growth. With a primary focus towards companies with novel medical device and molecular diagnostic technologies being commercialized in the U.S. and/or Europe, The Atticus Group’s expertise includes assessment of the clinical value, market potential and competitive advantages of new medical technologies and the development and implementation of strategic branding, marketing, reimbursement, economic messaging and clinical publication strategies that support product commercialization efforts.

For more information about The Atticus Group visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Larry Yost
since: 10/2009
Follow >
Visit website